You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

ORGATRAX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Orgatrax, and when can generic versions of Orgatrax launch?

Orgatrax is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in ORGATRAX is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.

Summary for ORGATRAX
Drug patent expirations by year for ORGATRAX
Anatomical Therapeutic Chemical (ATC) Classes for ORGATRAX

US Patents and Regulatory Information for ORGATRAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc ORGATRAX hydroxyzine hydrochloride INJECTABLE;INJECTION 087014-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon Usa Inc ORGATRAX hydroxyzine hydrochloride INJECTABLE;INJECTION 087014-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.